Sangamo BioSciences | SGMO - Pre Utilidad Fiscal

Precio De Mercado
0.25
Cambio Diario
-0.01 -4.09%
Mensual
-38.64%
Anual
-65.04%
Q2 Expectativa
0.24




Pre Utilidad Fiscal Cambio Fecha
Alaunos Therapeutics USD -7.84M 633K 2023-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Amgen USD 3.92B 2.35B 2025-09
Bayer EUR -1.16B 735M 2025-09
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Cipla INR 11.69B 6.85B 2025-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 56.84M 63.78M 2025-12
CSL USD 2.61B 1.21B 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Grifols EUR 257.85M 190.87M 2024-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
J&J USD 4.97B 2.53B 2025-12
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Merck USD 6.74B 22M 2025-09
Novartis USD 4.64B 445M 2025-12
Omeros USD -65.12M 21.27M 2024-06
Pfizer USD 3.33B 290M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Tectonic Therapeutic USD -18.97M 63K 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09